BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

765 related articles for article (PubMed ID: 12599223)

  • 1. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival.
    Zidan J; Karen D; Stein M; Rosenblatt E; Basher W; Kuten A
    Cancer; 2003 Mar; 97(5):1181-5. PubMed ID: 12599223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follicular variant of papillary thyroid carcinoma: a long-term follow-up.
    Passler C; Prager G; Scheuba C; Niederle BE; Kaserer K; Zettinig G; Niederle B
    Arch Surg; 2003 Dec; 138(12):1362-6. PubMed ID: 14662540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papillary and follicular variant of papillary carcinoma of the thyroid: Initial presentation and response to therapy.
    Burningham AR; Krishnan J; Davidson BJ; Ringel MD; Burman KD
    Otolaryngol Head Neck Surg; 2005 Jun; 132(6):840-4. PubMed ID: 15944551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central nodal metastases in papillary thyroid carcinoma based on tumor histologic type and focality.
    Salter KD; Andersen PE; Cohen JI; Schuff KG; Lester L; Shindo ML; Sauer D; Gross ND
    Arch Otolaryngol Head Neck Surg; 2010 Jul; 136(7):692-6. PubMed ID: 20644065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas.
    Chang HY; Lin JD; Chou SC; Chao TC; Hsueh C
    Jpn J Clin Oncol; 2006 Nov; 36(11):688-93. PubMed ID: 17000702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.
    Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
    Ann Surg Oncol; 2007 Feb; 14(2):730-8. PubMed ID: 17103065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papillary thyroid carcinoma: factors influencing recurrence and survival.
    Toniato A; Boschin I; Casara D; Mazzarotto R; Rubello D; Pelizzo M
    Ann Surg Oncol; 2008 May; 15(5):1518-22. PubMed ID: 18324441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment for microcarcinoma of the thyroid--clinical experience.
    Küçük NO; Tari P; Tokmak E; Aras G
    Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival in patients with papillary thyroid cancer is not affected by the use of radioactive isotope.
    Podnos YD; Smith DD; Wagman LD; Ellenhorn JD
    J Surg Oncol; 2007 Jul; 96(1):3-7. PubMed ID: 17567872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
    Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
    Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High recurrent rate of multicentric papillary thyroid carcinoma.
    Lin JD; Chao TC; Hsueh C; Kuo SF
    Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.
    Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH
    Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
    Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
    J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
    Vassilopoulou-Sellin R; Schultz PN; Haynie TP
    Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse sclerosing variant of papillary carcinoma of the thyroid: a 35-year comparative study at a single institution.
    Lam AK; Lo CY
    Ann Surg Oncol; 2006 Feb; 13(2):176-81. PubMed ID: 16411146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of tumor capsular invasion in well-differentiated thyroid carcinomas.
    Furlan JC; Bedard YC; Rosen IB
    Am Surg; 2007 May; 73(5):484-91. PubMed ID: 17521005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and prognostic significance of tall cell variant of papillary thyroid carcinoma.
    Michels JJ; Jacques M; Henry-Amar M; Bardet S
    Hum Pathol; 2007 Feb; 38(2):212-9. PubMed ID: 17097131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
    Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
    Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of previous radiation exposure on pathologic features and clinical outcome in patients with thyroid cancer.
    Seaberg RM; Eski S; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):355-9. PubMed ID: 19380356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.